European(EU) Pharmacopoeia, 11th Edition 欧州(EU ヨーロッパ)薬局方 (補遺11.6-補遺11.8) 書籍版

欧州(EU ヨーロッパ)薬局方 European(EU) Pharmacopoeia, 11th Edition (補遺11.6-補遺11.8) 書籍版

欧州・英国等各国薬局方  > 

欧州(EU ヨーロッパ)薬局方 European(EU) Pharmacopoeia, 11th Edition (補遺11.6-補遺11.8) 書籍版





European(EU) Pharmacopoeia 11th Edition (11.6-11.8)
欧州(EU ヨーロッパ)薬局方 第11版 (補遺11.6-補遺11.8)
発行年/月11.6 (2024年7月) 11.7 (2024年10月) 11.8 (2025年1月)


The European Pharmacopoeia (Ph. Eur.) is the primary source of official quality standards for medicines and their ingredients in Europe. Ph. Eur. standards provide a scientific basis for the quality control of a product throughout its life cycle, supporting the pharmaceutical industry and healthcare systems.

As laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in European Union and national pharmaceutical legislation, these standards are legally binding. They become mandatory on the same date in all states parties to the convention.

The 11th Edition key facts and figures

- New edition, legally binding in 39 European countries as of 1 January 2023 and applied in more than 130 countries worldwide.
- Continuously updated and modernised to meet users' needs.
- The 11th Edition of the Ph. Eur. contains:
  ・ 2469 monographs (including dosage forms)
  ・ 386 general texts (including general monographs and methods of analysis)
  ・and more than 2 800 descriptions of reagents
- Will be released in July 2022 and will be updated with eight periodic supplements over the following three years (11.1 to 11.8).